Analyses of brain samples from individuals with Alzheimer’s disease (AD) have shown that levels of the mitochondrial biogenesis transcriptional ‘master-regulator’ PGC-1α in hippocampal tissues are reduced relative to control tissue, suggesting that disruption of PGC-1α-dependent pathways contributes to pathogenesis14. Here, PPARGC1A is linked to Alzheimer disease.